Preimplantation genetic diagnosis: Recent triumphs and remaining challenges

Expert Review of Molecular Diagnostics

Volumn 12, Issue 6, 2012, Pages 585-592

  Sengupta, Sioban B ^a   Delhanty, Joy D A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

comparative genomic hybridization; embryo; FISH; IVF; PCR; preimplantation genetic diagnosis; preimplantation genetic screening

Indexed keywords

AUTOMATION; CHROMOSOME ABERRATION; COST CONTROL; DIAGNOSTIC PROCEDURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EMBRYO DEVELOPMENT; EMBRYOLOGY; FERTILIZATION IN VITRO; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE MUTATION; GENETIC ANALYSIS; GENETIC DISORDER; GENETIC RISK; GENETICS; HEALTH CARE COST; HUMAN; LABORATORY; MICROARRAY ANALYSIS; MOLECULAR DIAGNOSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PREGNANCY DISORDER; PREIMPLANTATION GENETIC DIAGNOSIS; REVIEW;

FERTILIZATION IN VITRO; GENETIC TESTING; GENOMICS; HUMANS; PREIMPLANTATION DIAGNOSIS;

EID: 84864613294     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/erm.12.61     Document Type: Review

References (83)

1. Harper JC, Sengupta SB. Preimplantation genetic diagnosis: State of the art 2011. Hum. Genet. 131(2), 175-186 (2012).
2. Harton G, Braude P, Lashwood A et al.; European Society for Human Reproduction and Embryology (ESHRE) PGD Consortium. ESHRE PGD Consortium best practice guidelines for organization of a PGD centre for PGD/ preimplantation genetic screening. Hum. Reprod. 26(1), 14-24 (2011).
3. Harper JC, Coonen E, De Rycke M et al. ESHRE PGD Consortium data collection X: Cycles from January to December 2007 with pregnancy follow-up to October 2008. Hum. Reprod. 25(11), 2685-2707 (2010).
4. Harper JC, Wilton L, Traeger-Synodinos J et al. The ESHRE PGD Consortium: 10 years of data collection. Hum. Reprod. Update. 18(3), 234-247 (2012).
5. Mastenbroek S, Twisk M, van Echten- Arends J et al. In vitro fertilization with preimplantation genetic screening. N. Engl. J. Med. 357(1), 9-17 (2007).
6. Raffan E, Semple RK. Next generation sequencing - Implications for clinical practice. Br. Med. Bull. 99, 53-71 (2011).
7. Tamhankar PM, Agarwal S, Arya V et al. Prevention of homozygous beta thalassemia by premarital screening and prenatal diagnosis in India. Prenat. Diagn. 29(1), 83-88 (2009). Erratum in: PRENAT. Diagn. 29(7), 732 (2009).
8. Cowan RS. Moving up the slippery slope: Mandated genetic screening on Cyprus. Am. J. Med. Genet. C Semin. Med. Genet. 51C(1), 95-103 (2009).
9. Memish ZA, Saeedi MY. Six-year outcome of the national premarital screening and genetic counseling program for sickle cell disease and b-thalassemia in Saudi Arabia. Ann. Saudi Med. 31(3), 229-235 (2011).
10. Wong LP, George E, Tan JA. Public perceptions and attitudes toward thalassaemia: Influencing factors in a multi-racial population. BMC Public Health 11, 193 (2011).
11. Comeau AM, Parad RB, Dorkin HL et al. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: A cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics 113(6), 1573-1581 (2004).
12. Poulou M, Fylaktou I, Fotoulaki M et al. Cystic fibrosis genetic counseling difficulties due to the identification of novel mutations in the CFTR gene. J. Cyst. Fibros. doi:10.1016/j.jcf.2012.01.004 (2012) (Epub ahead of print).
13. Bombieri C, Claustres M, De Boeck K et al. Recommendations for the classification of diseases as CFTR-related disorders. J. Cyst. Fibros. 10(Suppl. 2), S86-S102 (2011).
14. Goldsmith L, Jackson L, O'Connor A et al. Direct-to-consumer genomic testing: Systematic review of the literature on user perspectives. Eur. J. Hum. Genet. doi:10.1038/ejhg.2012.18. (2012) (Epub ahead of print).
15. Clementini E, Palka C, Iezzi I et al. Prevalence of chromosomal abnormalities in 2078 infertile couples referred for assisted reproductive techniques. Hum. Reprod. 20(2), 437-442 (2005).
16. Hofherr SE, Wiktor AE, Kipp BR et al. Clinical diagnostic testing for the cytogenetic and molecular causes of male infertility: The Mayo Clinic experience. J. Assist. Reprod. Genet. 28(11), 1091-1098 (2011).
17. van den Boogaard E, Hermens RP, Verhoeve HR et al. Selective karyotyping in recurrent miscarriage: Are recommended guidelines adopted in daily clinical practice? Hum. Reprod. 26(8), 1965-1970 (2011).
18. Alviggi C, Humaidan P, Ezcurra D. Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: Tools for matching patients and protocols. Reprod. Biol. Endocrinol. 10(1), 9 (2012).
19. Agarwal A, Said TM. Role of sperm chromatin abnormalities and DNA damage in male infertility. Hum. Reprod. Update 9(4), 331-345 (2003).
20. Wilding M, Coppola G, di Matteo L et al. Intracytoplasmic injection of morphologically selected spermatozoa (IMSI) improves outcome after assisted reproduction by deselecting physiologically poor quality spermatozoa. J. Assist. Reprod. Genet. 28(3), 253-262 (2011).
21. Souza Setti A, Ferreira RC, Paes De Almeida Ferreira Braga D et al. Intracytoplasmic sperm injection outcome versus intracytoplasmic morphologically selected sperm injection outcome: A meta-analysis. Reprod. Biomed. Online 21(4), 450-455 (2010).
22. Paes De Almeida Ferreira Braga D, De Cássia Savio Figueira R, Queiroz P et al. Zona pellucida birefringence in in vivo and in vitro matured oocytes. Fertil. Steril. 94(6), 2050-2053 (2010).
23. Montag M, Köster M, van Der Ven K et al. Gamete competence assessment by polarizing optics in assisted reproduction. Hum. Reprod. Update 17(5), 654-666 (2011).
24. Palermo G, Joris H, Devroey P, Van Steirteghem AC. Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte. Lancet 340(8810), 17-18 (1992).
25. Van Steirteghem A. Celebrating ICSI's twentieth anniversary and the birth of more than 2.5 million children - the 'how, why, when and where'. Hum. Reprod. 27(1), 1-2 (2012).
26. Goossens V, De Rycke M, De Vos A et al. Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. Hum. Reprod. 23(3), 481-492 (2008).
27. Liebaers I, Desmyttere S, Verpoest W et al. Report on a consecutive series of 581 children born after blastomere biopsy for preimplantation genetic diagnosis. Hum. Reprod. 25(1), 275-282 (2010).
28. Kirkegaard K, Hindkjaer JJ, Ingerslev HJ. Human embryonic development after blastomere removal: A time-lapse analysis. Hum. Reprod. 27(1), 97-105 (2012).
29. Schoolcraft WB, Treff NR, Stevens JM et al. Live birth outcome with trophectoderm biopsy, blastocyst vitrification, and single-nucleotide polymorphism microarray-based comprehensive chromosome screening in infertile patients. Fertil. Steril. 96(3), 638-640 (2011).
30. Mamas T, Gordon A, Brown A et al. Detection of aneuploidy by array comparative genomic hybridization using cell lines to mimic a mosaic trophectoderm biopsy. Fertil. Steril. 97(4), 943-947 (2012).
31. Van Landuyt L, Stoop D, Verheyen G et al. Outcome of closed blastocyst vitrification in relation to blastocyst quality: Evaluation of 759 warming cycles in a single-embryo transfer policy. Hum. Reprod. 26(3), 527-534 (2011).
32. Herrero L, Martínez M, Garcia-Velasco JA. Current status of human oocyte and embryo cryopreservation. Curr. Opin. Obstet. Gynecol. 23(4), 245-250 (2011).
33. Taylor TH, Gilchrist JW, Hallowell SV et al. The effects of different laser pulse lengths on the embryo biopsy procedure and embryo development to the blastocyst stage. J. Assist. Reprod. Genet. 27(11), 663-667 (2010).
34. Wininger JD, Taylor TH, Orris JJ et al. Pregnancy after rebiopsy and vitrification of blastocysts following allele dropout after day 3 biopsy. Fertil. Steril. 95(3), 1122.e1-2 (2011).
35. Nel-Themaat L, Nagy ZP. A review of the promises and pitfalls of oocyte and embryo metabolomics. Placenta 32(Suppl. 3), S257-S263 (2011).
36. Sturmey RG, Hawkhead JA, Barker EA et al. DNA damage and metabolic activity in the preimplantation embryo. Hum. Reprod. 24(1), 81-91 (2009).
37. Wong CC, Loewke KE, Bossert NL et al. Non-invasive imaging of human embryos before embryonic genome activation predicts development to the blastocyst stage. Nat. Biotechnol. 28(10), 1115-1121 (2010).
38. Coulam CB, Acacio B. Does immunotherapy for treatment of reproductive failure enhance live births? Am. J. Reprod. Immunol. 67(4), 296-304 (2012).
39. Bansal AS, Bajardeen B, Thum MY. The basis and value of currently used immunomodulatory therapies in recurrent miscarriage. J. Reprod. Immunol. 93(1), 41-51 (2012).
40. Chang EM, Han JE, Kim YS et al. Use of the natural cycle and vitrification thawed blastocyst transfer results in better in-vitro fertilization outcomes: Cycle regimens of vitrification thawed blastocyst transfer. J. Assist. Reprod. Genet. 28(4), 369-374 (2011).
41. Zhu D, Zhang J, Cao S et al. Vitrified- warmed blastocyst transfer cycles yield higher pregnancy and implantation rates compared with fresh blastocyst transfer cycles - time for a new embryo transfer strategy? Fertil. Steril. 95(5), 1691-1695 (2011).
42. Harper J, Magli MC, Lundin K et al. When and how should new technology be introduced into the IVF laboratory? Hum. Reprod. 27(2), 303-313 (2012).
43. Fiorentino F, Biricik A, Nuccitelli A et al. Strategies and clinical outcome of 250 cycles of preimplantation genetic diagnosis for single gene disorders. Hum. Reprod. 21(3), 670-684 (2006).
44. Rechitsky S, Pomerantseva E, Pakhalchuk T et al. First systematic experience of preimplantation genetic diagnosis for de-novo mutations. Reprod. Biomed. Online 22(4), 350-361 (2011).
45. Altarescu G, Brooks B, Kaplan Y et al. Single-sperm analysis for haplotype construction of de-novo paternal mutations: Application to PGD for neurofibromatosis type 1. Hum. Reprod. 21(8), 2047-2051 (2006).
46. Altarescu G, Eldar-Geva T, Varshower I et al. Real-time reverse linkage using polar body analysis for preimplantation genetic diagnosis in female carriers of De novo mutations. Hum. Reprod. 24(12), 3225-3229 (2009).
47. Kakourou G, Dhanjal S, Daphnis D. Preimplantation genetic diagnosis for myotonic dystrophy type 1: Detection of crossover between the gene and the linked marker APOC2. Prenat. Diagn. 27(2), 111-116 (2007).
48. Moutou C, Gardes N, Viville S. Multiplex PCR combining deltaF508 mutation and intragenic microsatellites of the CFTR gene for pre-implantation genetic diagnosis (PGD) of cystic fibrosis. Eur. J. Hum. Genet. 10(4), 231-238 (2002).
49. Piyamongkol W, Harper JC, Sherlock JK et al. A successful strategy for preimplantation genetic diagnosis of myotonic dystrophy using multiplex fluorescent PCR. Prenat. Diagn. 21(3), 223-232 (2001).
50. Harton GL, De Rycke M, Fiorentino F et al.; European Society for Human Reproduction and Embryology (ESHRE) PGD Consortium. ESHRE PGD Consortium best practice guidelines for amplification-based PGD. Hum. Reprod. 26(1), 33-40 (2011).
51. Altarescu G, Eldar Geva T, Brooks B et al. PGD on a recombinant allele: Crossover between the TSC2 gene and 'linked' markers impairs accurate diagnosis. Prenat. Diagn. 28(10), 929-933 (2008).
52. Van De Velde H, De Rycke M, De Man C et al. The experience of two European preimplantation genetic diagnosis centres on human leukocyte antigen typing. Hum. Reprod. 24(3), 732-740 (2009).
53. Fiorentino F, Kokkali G, Biricik A et al. Polymerase chain reaction-based detection of chromosomal imbalances on embryos: The evolution of preimplantation genetic diagnosis for chromosomal translocations. Fertil. Steril. 94(6), 2001-2011, 2011.e1-6 (2010).
54. Sherlock J, Cirigliano V, Petrou M et al. Assessment of diagnostic quantitative fluorescent multiplex polymerase chain reaction assays performed on single cells. Ann. Hum. Genet. 62(Pt 1), 9-23 (1998).
55. Sato T, Ikuta K, Sherlock J et al. Comparison between fluorescence in situ hybridization (FISH) and quantitative-fluorescent polymerase chain reaction (QF-PCR) for the detection of aneuploidies in single blastomeres. Prenat. Diagn. 23(8), 678-684 (2003).
56. Bergen AW, Haque KA, Qi Y et al. Comparison of yield and genotyping performance of multiple displacement amplification and OmniPlex whole genome amplified DNA generated from multiple DNA sources. Hum. Mutat. 26(3), 262-270 (2005).
57. Lasken RS. Genomic DNA amplification by the multiple displacement amplification (MDA) method. Biochem. Soc. Trans. 37(Pt 2), 450-453 (2009).
58. Glentis S, SenGupta S, Thornhill A et al. Molecular comparison of single cell MDA products derived from different cell types. Reprod. Biomed. Online. 19(1), 89-98 (2009).
59. Renwick P, Trussler J, Lashwood A et al. Preimplantation genetic haplotyping: 127 diagnostic cycles demonstrating a robust, efficient alternative to direct mutation testing on single cells. Reprod. Biomed. Online. 20(4), 470-476 (2010).
60. Langmore JP. Rubicon Genomics, Inc. Pharmacogenomics 3(4), 557-560 (2002).
61. Harper JC, Harton G. The use of arrays in preimplantation genetic diagnosis and screening. Fertil. Steril. 94(4), 1173-1177 (2010).
62. Handyside AH, Harton GL, Mariani B et al. Karyomapping: A universal method for genome wide analysis of genetic disease based on mapping crossovers between parental haplotypes. J. Med. Genet. 47(10), 651-658 (2010).
63. Treff NR, Northrop LE, Kasabwala K et al. Single nucleotide polymorphism microarray-based concurrent screening of 24-chromosome aneuploidy and unbalanced translocations in preimplantation human embryos. Fertil. Steril. 95(5), 1606-1612.e1-2 (2011).
64. Fiorentino F, Spizzichino L, Bono S et al. PGD for reciprocal and Robertsonian translocations using array comparative genomic hybridization. Hum. Reprod. 26(7), 1925-1935 (2011).
65. Geraedts J, Montag M, Magli MC et al. Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: Clinical results. Hum. Reprod. 26(11), 3173-3180 (2011).
66. Bisignano A, Wells D, Harton G et al. PGD and aneuploidy screening for 24 chromosomes: Advantages and disadvantages of competing platforms. Reprod. Biomed. Online 23(6), 677-685 (2011).
67. Handyside AH. PGD and aneuploidy screening for 24 chromosomes by genome-wide SNP analysis: Seeing the wood and the trees. Reprod. Biomed. Online 23(6), 686-691 (2011).
68. Harper JC, Delhanty JD. FISH in preimplantation diagnosis. Methods Mol. Med. 5, 259-268 (1996).
69. Ioannou D, Meershoek EJ, Thornhill AR et al. Multicolour interphase cytogenetics: 24 chromosome probes, 6 colours, 4 layers. Mol. Cell. Probes 25(5-6), 199-205 (2011).
70. Vanneste E, Melotte C, Debrock S et al. Preimplantation genetic diagnosis using fluorescent in situ hybridization for cancer predisposition syndromes caused by microdeletions. Hum. Reprod. 24(6), 1522-1528 (2009).
71. Mantzouratou A, Delhanty JD. Aneuploidy in the human cleavage stage embryo. Cytogenet. Genome Res. 133(2-4), 141-148 (2011).
72. Treff NR, Tao X, Schillings WJ et al. Use of single nucleotide polymorphism microarrays to distinguish between balanced and normal chromosomes in embryos from a translocation carrier. Fertil. Steril. 96(1), e58-e65 (2011).
73. Steffann J, Frydman N, Gigarel N et al. Analysis of mtDNA variant segregation during early human embryonic development: A tool for successful NARP preimplantation diagnosis. J. Med. Genet. 43(3), 244-247 (2006).
74. Unsal E, Aktaş Y, Uner O et al. Successful application of preimplantation genetic diagnosis for Leigh syndrome. Fertil. Steril. 90(5), 2017.e11-13 (2008).
75. Dimauro S, Davidzon G. Mitochondrial DNA and disease. Ann Med. 37(3), 222-232 (2005).
76. Poulton J, Chiaratti MR, Meirelles FV et al. Transmission of mitochondrial DNA diseases and ways to prevent them. PLoS Genet. 6(8), pii: E1001066 (2010).
77. Craven L, Tuppen HA, Greggains GD et al. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 465(7294), 82-85 (2010).
78. Vanneste E, Voet T, Melotte C et al. What next for preimplantation genetic screening? High mitotic chromosome instability rate provides the biological basis for the low success rate. Hum. Reprod. 24(11), 2679-2682 (2009).
79. Palini S, De Stefani S, Scala V et al. Epigenetic regulatory mechanisms during preimplantation embryo development. Ann. NY Acad. Sci. 1221, 54-60 (2011).
80. van Montfoort AP, Hanssen LL, De Sutter P et al. Assisted reproduction treatment and epigenetic inheritance. Hum. Reprod. Update 18(2), 171-197 (2012).
81. Grace KS, Sinclair KD. Assisted reproductive technology, epigenetics, and long-term health: A developmental time bomb still ticking. Semin. Reprod. Med. 27(5), 409-416 (2009).
82. Kroneis T, Geigl JB, El-Heliebi A et al. Combined molecular genetic and cytogenetic analysis from single cells after isothermal whole-genome amplification. Clin. Chem. 57(7), 1032-1041 (2011).
83. Hou Y, Song L, Zhu P et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 148(5), 873-885 (2012).